Zobrazeno 1 - 10
of 853
pro vyhledávání: '"Palmieri Giuseppe"'
Autor:
Colombino, Maria, Casula, Milena, Paliogiannis, Panagiotis, Manca, Antonella, Sini, Maria Cristina, Pisano, Marina, Santeufemia, Davide Adriano, Cossu, Antonio, Palmieri, Giuseppe
Publikováno v:
In Critical Reviews in Oncology / Hematology September 2024 201
Autor:
Colombino, Maria1 (AUTHOR) maria.colombino@cnr.it, Palmieri, Giuseppe2 (AUTHOR) gpalmieri@uniss.it, Rodio, Manuela3,4 (AUTHOR) m.rodio@studenti.uniss.it, Tettamanzi, Matilde3,4 (AUTHOR) m.tettamanzi@studenti.uniss.it, Rampazzo, Silvia3,4 (AUTHOR) s.rampazzo93@studenti.uniss.it, Margani, Raffaello3,5 (AUTHOR) r.margani@studenti.uniss.it, Trignano, Emilio3,5 (AUTHOR) emilio.trignano@aouss.it, Cossu, Antonio6 (AUTHOR) antonio.cossu@aouss.it, Fedeli, Maria Antonietta6 (AUTHOR) mariantonietta.fedeli@aousassari.it, Fadda, Giovanni Maria7 (AUTHOR) giovanni.fadda@aouss.it, Rubino, Corrado3,5 (AUTHOR) corubino@uniss.it
Publikováno v:
Cancers. Jun2024, Vol. 16 Issue 11, p1956. 12p.
Autor:
Gentilcore Giusy, Madonna Gabriele, Mozzillo Nicola, Ribas Antoni, Cossu Antonio, Palmieri Giuseppe, Ascierto Paolo A
Publikováno v:
BMC Cancer, Vol 13, Iss 1, p 17 (2013)
Abstract Background Conventional therapeutic agents are largely unsatisfactory into the treatment of malignant melanoma. Recently, an innovative approach based on inhibitors of the mutated BRAF gene (which represents the most prevalent alteration in
Externí odkaz:
https://doaj.org/article/00c3a3a755b34f338a7149a6d5b5d3df
Autor:
De Logu, Francesco, Ugolini, Filippo, Iannone, Luigi Francesco, Simi, Sara, Maio, Vincenza, de Giorgi, Vincenzo, Maria di Giacomo, Anna, Miracco, Clelia, Cossu, Antonio, Palmieri, Giuseppe, Mandalà, Mario, Massi, Daniela
Publikováno v:
In Laboratory Investigation December 2023 103(12)
Autor:
Caporali Simona, Levati Lauretta, Graziani Grazia, Muzi Alessia, Atzori Maria Grazia, Bonmassar Enzo, Palmieri Giuseppe, Ascierto Paolo A, D’Atri Stefania
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss 1, p 252 (2012)
Abstract Background Most DNA-damaging chemotherapeutic agents activate the transcription factor nuclear factor κB (NF-κB). However, NF-κB activation can either protect from or contribute to the growth suppressive effects of the agent. We previousl
Externí odkaz:
https://doaj.org/article/7d55a0d05d2e48328b90f654b0509e26
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raimondi Sara, Gandini Sara, Fargnoli Maria, Bagnardi Vincenzo, Maisonneuve Patrick, Specchia Claudia, Kumar Rajiv, Nagore Eduardo, Han Jiali, Hansson Johan, Kanetsky Peter A, Ghiorzo Paola, Gruis Nelleke A, Dwyer Terry, Blizzard Leigh, Fernandez-de-Misa Ricardo, Branicki Wojciech, Debniak Tadeusz, Morling Niels, Landi Maria, Palmieri Giuseppe, Ribas Gloria, Stratigos Alexander, Cornelius Lynn, Motokawa Tomonori, Anno Sumiko, Helsing Per, Wong Terence H, Autier Philippe, García-Borrón José C, Little Julian, Newton-Bishop Julia, Sera Francesco, Liu Fan, Kayser Manfred, Nijsten Tamar
Publikováno v:
BMC Medical Research Methodology, Vol 12, Iss 1, p 116 (2012)
Abstract Background For complex diseases like cancer, pooled-analysis of individual data represents a powerful tool to investigate the joint contribution of genetic, phenotypic and environmental factors to the development of a disease. Pooled-analysi
Externí odkaz:
https://doaj.org/article/ccc664ceca024aa0ab13bec99a47a533
Autor:
Palomba Grazia, Colombino Maria, Contu Antonio, Massidda Bruno, Baldino Giovanni, Pazzola Antonio, Ionta MariaTeresa, Capelli Francesca, Trova Vittorio, Sedda Tito, Sanna Giovanni, Tanda Francesco, Budroni Mario, Palmieri Giuseppe, Cossu Antonio
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss 1, p 178 (2012)
Abstract Background Role of KRAS, BRAF and PIK3CA mutations in pathogenesis of colorectal cancer (CRC) has been recently investigated worldwide. In this population-based study, we evaluated the incidence rates and distribution of such somatic mutatio
Externí odkaz:
https://doaj.org/article/214b4ee0aa8042b3b728ef435f405fd2
Autor:
Ascierto Paolo A, Kirkwood John M, Grob Jean-Jacques, Simeone Ester, Grimaldi Antonio M, Maio Michele, Palmieri Giuseppe, Testori Alessandro, Marincola Francesco M, Mozzillo Nicola
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss 1, p 85 (2012)
Abstract BRAF is a serine/threonine protein kinase activating the MAP kinase/ERK-signaling pathway. About 50 % of melanomas harbors activating BRAF mutations (over 90 % V600E). BRAFV600E has been implicated in different mechanisms underlying melanoma
Externí odkaz:
https://doaj.org/article/e34aa8e10db24e9dba9f6feb4558168b